candesartan cilexetil has been researched along with ADPKD in 3 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of the present study was to determine whether urinary L-FABP excretion is altered in patients with autosomal dominant polycystic kidney disease (ADPKD) and whether candesartan cilexetil, an angiotensin II receptor antagonist, affects these levels." | 5.11 | Candesartan reduces urinary fatty acid-binding protein excretion in patients with autosomal dominant polycystic kidney disease. ( Kawagoe, Y; Koide, H; Nakamura, T; Osada, S; Sugaya, T; Ueda, Y, 2005) |
| "Here, we present an ADPKD patient with enlarged kidneys due to multiple cysts who had a decreased soluble Klotho level but a normal eGFR and a normal FGF23 level." | 1.48 | A decreased soluble Klotho level with normal eGFR, FGF23, serum phosphate, and FEP in an ADPKD patient with enlarged kidneys due to multiple cysts. ( Aoyagi, J; Betsui, H; Kanai, T; Shiizaki, K; Yamagata, T, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanai, T | 1 |
| Shiizaki, K | 1 |
| Betsui, H | 1 |
| Aoyagi, J | 1 |
| Yamagata, T | 1 |
| Nakamura, T | 2 |
| Sugaya, T | 1 |
| Kawagoe, Y | 1 |
| Ueda, Y | 1 |
| Osada, S | 1 |
| Koide, H | 2 |
| Ushiyama, C | 1 |
| Shimada, N | 1 |
| Sekizuka, K | 1 |
| Ebihara, I | 1 |
2 trials available for candesartan cilexetil and ADPKD
| Article | Year |
|---|---|
Candesartan reduces urinary fatty acid-binding protein excretion in patients with autosomal dominant polycystic kidney disease.
Topics: Adult; Aged; Benzimidazoles; Biphenyl Compounds; Double-Blind Method; Female; Humans; Male; Middle A | 2005 |
Effects of the angiotensin II receptor antagonist candesartan cilexetil on blood pressure and proteinuria in patients with autosomal dominant polycystic kidney disease.
Topics: Adult; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds | 2000 |
1 other study available for candesartan cilexetil and ADPKD
| Article | Year |
|---|---|
A decreased soluble Klotho level with normal eGFR, FGF23, serum phosphate, and FEP in an ADPKD patient with enlarged kidneys due to multiple cysts.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blocker | 2018 |